Pending on what the update tomorrow brings.
If there’s no timeline for the animal test or even a possible start date mentioned this will probably drop to the low .04 for awhile.
Now if there’s a timeline announced with a actual start date, there will probably still be a drop in price for a little while but I can see a gradual increase towards the end of the time line. How much of a increase that’s a tough one, it’s possible we could be in the .10-.20 range by the end of testing. Fda likes the test results and gives us the thumbs up to submit the ide application. That could put possibly put us in a higher range possibly could be sitting around .50 a share before the news of the actual ide submittal.
If this actually happens news of the ide submittal could possibly push close to a dollar, and then for 30 days it will have some crazy swings up and down but as we get closer to the end of the 30 day window it very well could be a dollar possibly higher.
Ide approval will launch this and possibly get $5.00 plus.
Long term this easily $10 plus all day. Potential buyout Will possibly happen after phase completion and approval to move to phase 3.
Time line ide submittal in the next 1-1/2 to 3 months. Maybe sooner if they were able to start right away.
You have to understand that there’s lots of eyes on this and waiting for the ide submittal news to hit. It will be a rat race when that news hits.
My opinion of you truly believe in this company. I would be buying as much as I can at these levels. Sell a percentage on the ide submittal run, then sell a little more on approval then hold the rest for a possible buyout or full blown approval.
Also keep in mind isopet it’s not a big money maker yet, but it will be soon enough, so any major increase in revenue with this will also start to push the price as well. But they have a ways to go.
